Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
3.800
-0.130 (-3.31%)
At close: Jun 26, 2026, 4:00 PM EDT
3.809
+0.009 (0.23%)
After-hours: Jun 26, 2026, 7:38 PM EDT
Quantum BioPharma Employees
Quantum BioPharma had 17 employees as of December 31, 2022. The number of employees increased by 7 or 70.00% compared to the previous year.
Employees
17
Change (1Y)
7
Growth (1Y)
70.00%
Revenue / Employee
n/a
Profits / Employee
-$1,832,874
Market Cap
24.17M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 17 | 7 | 70.00% |
| Dec 31, 2021 | 10 | 1 | 11.11% |
| Dec 31, 2020 | 9 | -9 | -50.00% |
| Dec 31, 2019 | 18 | -1 | -5.26% |
| Dec 31, 2018 | 19 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| IGC Pharma | 70 |
| Evaxion | 46 |
| Vistagen Therapeutics | 41 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
| Serina Therapeutics | 16 |
| Neuphoria Therapeutics | 8 |
QNTM News
- 1 day ago - NetworkNewsAudio Announces Audio Press Release (APR) the Advancement of First-in-Class Treatment for Multiple Sclerosis - GlobeNewsWire
- 2 days ago - Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy - GlobeNewsWire
- 4 days ago - Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach - GlobeNewsWire
- 25 days ago - IBN Announces Latest Episode of The BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd. - GlobeNewsWire
- 26 days ago - Quantum BioPharma Engages Stocks.news For Investor Relations, Marketing Services And Lead Generation Campaigns - GlobeNewsWire
- 26 days ago - Quantum BioPharma Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital - GlobeNewsWire
- 7 weeks ago - Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026 - GlobeNewsWire